Scleroza multiplă

Scleroza multiplă


  1. Dobson R, Dassan P, Roberts M, Giovanonni G, Nelson-Piercy C, Brex PA. UK consensus on pregnancy in multiple sclerosis: ”Association of British Neurologists” Guidelines.Pract Neurol .2019;19:106–114. doi:10.1136/practneurol-2018002060.
  2. Coyle PK, Oh J, Magyari M, Oreja-Guevara C, Houtchens M. Management strategies for female patients of reproductive potential with multiple sclerosis: An evidence-based review. Multiple Sclerosis and Related Disorders. 2019;32:54–63.
  3. Wynn DR. Enduring Clinical Value of Copaxone (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use. Hindawi Multiple Sclerosis International 2019. Article ID 7151685. 19 pages.
  4. Tisovic K, Amezcua L. Women’s Health: Contemporary Management of MS in Pregnancy and Post-Partum. Biomedicines 2019;7:32; doi:10.3390/biomedicines7020032.
  5. Zuluaga MI, Otero-Romero S et al. Menarche, pregnancies, and breastfeeding do not modify long-term prognosis in multiple sclerosis. Neurology. 2019; March; 92 (13): e1507-1516.
  6. Fragoso YD, Aldoni T et al. Practical Evidence-Based Recommendations for Patients with Multiple Sclerosis Who Want to Have Children. Neurol Ther.2018;7:207–232.
  7. MacDonald SC, McElrath T, Hernandez-Diaz S. Use and safety of disease‐modifying therapy in pregnant women with multiple sclerosis. Pharmacoepidemiol Drug Saf. 2019;28:556–560.
  8. Sandberg-Wollheim M, Neudorfer O et al. Pregnancy Outcomes from the Branded Glatiramer Acetate Pregnancy Database. International Journal of MS Care. 2018 Consortium of Multiple Sclerosis Centers. DOI: 10.7224/1537-2073.2016079.
  9. Howard J. Multiple sclerosis. Questions and answers for patients and loved ones. DemosHealth USA 2019. ISBN: 9780826177469.
  10. Pirko I, Noseworthy JH. Demyelinating Disorders of the Central Nervous System. Textbook of Clinical Neurology. Ediția a 3-a, Chicago, Saunders Elsevier 2007.
  11. Harandi AA et al. Vitamine d and Multiple Sclerosis. Iran J Neurol.2014;13(1):1-6.
  12. Tsui A, Lee MA. Multiple sclerosis and pregnancy. Current Opinion in Obstetrics and Gynecology. 2011;23 (6):435-439.
  13. Sharrack B, Hughes RA. Clinical scales for multiple sclerosis. J Neurol Sci.1996;135(1):1-9.
  14. Rojas JI, Patrucco L, Miguez J, Cristiano E. Brain atrophy in multiple sclerosis:therapeutic, cognitive and clinical impact. Arq Neuropsiquiatr. 2016;74(3):235-43.
  15. Mihăilescu G. Tratamentul sclerozei multiple. Viața Medicală. 2018; 24 (6): pg 5.
  16. Mihăilescu G. Sarcina la femeile cu scleroză multiplă nu este una cu risc crescut. Viața Medicală 2019; 21 (1529): pg8-9.
  17. Montalban X et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Eur.J.Neurol.2018;25:215-237.
  18. Bajenaru O. Ghiduri de diagnostic și tratament in neurologie. Ed a 2-a. București. Amaltea. 2010.

Material realizat de catre Dr. Gabriela Mihăilescu Medic primar neurolog – Spitalul Clinic Colentina Șef de lucrări – UMF Carol Davila București


Cum se diagnostichează scleroza multiplă?
Ce este scleroza multiplă?
Diagnosticul paraclinic